Victory Capital Management Inc Gracell Biotechnologies Inc. Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$1.83 - $5.52 $109,635 - $330,703	-59,910 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$5.65 - $14.9 $14,972 - $39,485	-2,650 Reduced 4.24%	59,910 $362,000
Q3 2021 Nov 02, 2021	SELL	$9.91 - $14.84 $6,639 - $9,942	-670 Reduced 1.06%	62,560 $868,000
Q2 2021 Aug 03, 2021	SELL	$9.75 - $18.42 $35,295 - $66,680	-3,620 Reduced 5.42%	63,230 $822,000
Q1 2021 May 04, 2021	BUY	$14.7 - $30.57 $982,695 - $2.04 Million	66,850 New	66,850 $1.03 Million

75.1K

Ticker GRCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,674,096
Description
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.